Research Papers

Have a look in some of our latest articles

In the recent years, several projects have been carried out including the assessment of technologies for different clinical conditions and the evaluation of clinical pharmacy services around the world.



  • Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review. Inflamm Res. 2022;71(12):1489-1500.
  • The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review. Phytother Res. 2022;36(7):2686-2709.
  • Confusing terminology used in the abbreviation of pharmacy journal names. Res Social Adm Pharm. 2022;18(8):3463-3465
  • Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents. J Infect Chemother. 2022;28(12):1645-1653.
  • Use of ‘Pharmaceutical services’ Medical Subject Headings (MeSH) in articles assessing pharmacists’ interventions. Explor Res Clin Soc Pharm. 2022;7:100172.


  • Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus. Pulmonology. 2021;27(4):313-327.
  • Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21-29.
  • Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). Jan-Mar 2021;19(1):2302.
  • Publication speed in pharmacy practice journals: A comparative analysis.  Plos One. 2021 Jun 29;16(6):e0253713.
  • Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia. Diseases. 2021 Jun 15;9(2):43.
  • Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review. Res Social Adm Pharm. 2021 Jun 8;S1551-7411(21)00204-7.
  • Portuguese Consensus and Recommendations for Acquired Coagulopathic Bleeding Management (CCBM). Clin Appl Thromb Hemost. Jan-Dec 2021;27.
  • Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. Plos One. 2021 Jun 4;16(6):e0252529.
  • Influence of foods and nutrients on COVID-19 recovery: A multivariate analysis of data from 170 countries using a generalized linear model. Clin Nutr. 2021 Mar 22;S0261-5614(21)00157-6.
  • Identifying Training Needs and Active Information Opportunities in Primary Care Through the Analysis of Drug Information Requests. J Pharm Pract. 2021 Mar 5;897190021996976.
  • Implications of a defined daily dose fixed database for drug utilization research studies: The case of statins in Portugal. Br J Clin Pharmacol. 2021;87(9):3542-3549.
  • Standardization of pharmacy practice terminology and the Medical Subject Headings (MeSH). Res Social Adm Pharm. 2021 Apr;17(4):819-820.


  • A multivariate analysis of risk factors associated with death by Covid-19 in the USA, Italy, Spain, and Germany. Z Gesundh Wiss. 2020 Oct 19:1-7.
  • Pharmacy practice research – A call to action. Res Social Adm Pharm. 2020 Nov;16(11):1602-1608.
  • Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One. 2020 Sep 18;15(9):e0238910.
  • Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis. J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):399-408.
  • Stakeholder analysis in health innovation planning processes: A systematic scoping review. Health Policy. 2020 Oct;124(10):1083-1099.
  • Efficacy outcomes reported in trials of multiple sclerosis: A systematic scoping review. Mult Scler Relat Disord. 2020 Oct;45:102435.
  • Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis. World J Urol. 2020 May 9.
  • Contribution of Different Patient Information Sources to Create the Best Possible Medication History. Acta Med Port. 2020 Jun 1;33(6):384-389.
  • An international series on the integration of community pharmacy in primary health care. Pharm Pract (Granada). 2020;18(1):1878.
  • Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis. J Dermatolog Treat. 2020 Feb 20:1-10.
  • Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review. Plos One. 2020 Jun 16;15(6):e0231722.
  • How many manuscripts should I peer review per year? Pharm Pract (Granada). Jan-Mar 2020;18(1):1804.


  • Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysis. Br J Clin Pharmacol. 2019 Oct;85(10):2280-2291.
  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value Health Reg Issues. 2019 Dec;20:95-102.
  • Systematic Review and meta-analysis of medication reviews conducted by pharmacists on cardiovascular diseases risk factors in ambulatory care. J Am Hear Assoc. 2019. Nov 19;8(22):e013627.
  • Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis. Mult Scler Relat Disord. 2019 Jun 29;35:7-15.
  • Characterization of pharmacy practice research centers across the United States. Res Social Adm Pharm. 2019 May 22.
  • Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review.   2019 Apr 1;48(2):620-632.
  • Peer review and publication delay. Pharm Pract (Granada). 2019 Jan-Mar;17(1):1502.
  • Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies. Diagn Microbiol Infect Dis. 2019 May;94(1):41-49.
  • Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions. Int J Clin Pharm. Jun;41(3):785-792.
  • Temporal effectiveness of interventions to improve medication adherence: A network meta-analysis. Plos One. 2019 Mar 12;14(3):e0213432.
  • Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: Systematic Review. Curr Neuropharmacol. 2019;17(10):916-925.
  • Description of network meta-analysis geometry: A metrics design study. Plos One.  2019 Feb 20;14(2):e0212650.
  • An innovative and comprehensive technique to evaluate different measures of medication adherence: The network meta-analysis. Res Social Adm Pharm. 2019 Apr;15(4):358-365.
  • A Global Comparison of Internationalization Support Characteristics Available on College of Pharmacy Websites. Am J Pharm Educ . 2019 Apr;83(3):659
  • Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy. Front Pharmacol.  2019 Feb 26;10:130.
  • A model for the financial assessment of professional services in community pharmacy: A systematic review. J Am Pharmac Assoc (2003) 2019 Jan – Feb;59(1):108-116.


  • Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis. Eur J Cancer. 20185;104:9-20.
  • Cost-effectiveness of acromegaly treatments: a systematic review.  2018;21(6):642-652.
  • Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018 Nov;74(11):1513-1521.
  • Medical Treatments for Acromegaly: A Systematic Review and Network Meta-Analysis. Value Health. 2018 Jul;21(7):874-880.
  • Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis. CNS Drugs. 2018 Jul 16.
  • Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections. Mycoses. 2018;61(10):754-763.
  • Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS). BioDrugs. 2018;32(4):377-390.
  • Sustained Virological Response in Special Populations with Chronic Hepatitis C Using Interferon-Free Treatments: A Systematic Review and Meta-analysis of Observational Cohort Studies. Clin Drug Investig. 2018;38(5):389-400.
  • Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial. Clinics (Sao Paulo). 2018;73.
  • Mapping the characteristics of network meta-analyses on drug therapy: A systematic review. PLoS One. 2018;13(4).
  • Pharmacist-led discharge medication counselling: A scoping review. J Eval Clin Pract. 2018 Jun;24(3):570-579.
  • A case study of polypharmacy management in nine European countries: Implications for change management and implementation. PLoS One. 2018 Apr 18;13(4).
  • Cross-cultural adaptation and validation of a European Portuguese version of the 8-item Morisky medication adherence scale. Rev Port Cardiol. 2018 Apr;37(4).
  • Direct costs of type 2 diabetes: a brazilian cost-of-illness study. Int J Technol Assess Health Care. 2018 Jan;34(2).
  • Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2018;10:18.
  • Characterization of pharmacists’ interventions in asthma management: A systematic review. J Am Pharm Assoc (2003). 2018;58(2).
  • Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis. Eur Child Adolesc Psychiatry. 2018;27(10):1335-1345.
  • Developing an adherence in hypertension questionnaire short version: MUAH-16. J Clin Hypertens (Greenwich). 2018;20(1).


  • Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews. Pharm Pract (Granada). 2017;15(4).
  • A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS One. 2017;12(11).
  • Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study.  Regul Toxicol Pharmacol. 2017;90:87-94.
  • Redefining the pharmacology and pharmacy subject category in the journal citation reports using medical subject headings (MeSH). Int J Clin Pharm. 2017;39(5):989-997.
  • Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis. J Pharm Pharmacol. 2017;69(12):1672-1683.
  • A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients. J Clin Pharm Ther. 2017;42(5):530-538.
  • New pharmacy-specific Medical Subject Headings included in the 2017 database. Am J Health Syst Pharm. 2017;74(15):1128-1129.
  • Influence of the mode of administration on the results of medication adherence questionnaires. J Eval Clin Pract. 2017;23(6):1252-1257.
  • Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics (Sao Paulo). 2017;72(5):317-324.
  • Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis. J Pediatr. 2017;185:129-135.
  • Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review. Health Educ Behav. 2017;44(4):524-535.
  • Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses. J Atten Disord. 2019;23(2):111-120.
  • Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study. Ther Clin Risk Manag. 2017 Jan 10;13:59-64.
  • Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis. Mycoses. 2017;60(3):146-154.
  • Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24. Eur J Clin Pharmacol. 2017;73(1):1-14.
  • Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics. Pharmacogenomics J. 2017;17(6):488-493.


  • Analysis of ten years of publishing in Pharmacy Practice. Pharm Pract (Granada). 2016 Oct-Dec;14(4):847.
  • Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy. Core Evid. 2016 Dec 14;11:49-61.
  • Current perceptions of the term Clinical Pharmacy and its relationship to Pharmaceutical Care: a survey of members of the European Society of Clinical Pharmacy. Int J Clin Pharm. 2016;38(6):1445-1456.
  • A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe. Am J Pharm Educ. 2016;80(5):83.
  • A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease. J Manag Care Spec Pharm. 2016 Jun;22(6):699-713.
  • Safety of interferon-free therapies for chronic hepatitis C: a network meta-analysis. J Clin Pharm Ther. 2016 Oct;41(5):478-85.
  • Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions. Int J Clin Pharm. 2016 Apr;38(2):362-73.
  • Pharmacists’ interventions on clinical asthma outcomes: a systematic review. Eur Respir J. 2016 Apr;47(4):1134-43.
  • Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective. Patient Educ Couns. 2016 Mar;99(3):339-347.
  • Update on Biologic Therapies for Systemic Lupus Erythematosus. Curr Rheumatol Rep. 2016 Jul;18(7):44.